- Home
- PROK vs BWFG Comparison
PROK vs BWFG Comparison
Compare PROK & BWFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PROK | BWFG |
|---|---|---|
| Founded | 2015 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 331.2M | 394.0M |
| IPO Year | 2021 | 2014 |
Fundamental Metrics
Financial Performance| Metric | PROK | BWFG |
|---|---|---|
| Price | $2.09 | $48.51 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | $7.40 | ★ $55.00 |
| AVG Volume (30 Days) | ★ 844.7K | 21.2K |
| Earning Date | 02-21-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 1.66% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.29 |
| Revenue | $76,000.00 | ★ $1,963,000.00 |
| Revenue This Year | $1,010.19 | $17.64 |
| Revenue Next Year | N/A | $6.21 |
| P/E Ratio | ★ N/A | $14.59 |
| Revenue Growth | N/A | ★ 20.50 |
| 52 Week Low | $0.46 | $26.39 |
| 52 Week High | $7.13 | $51.54 |
Technical Indicators
Market Signals| Indicator | PROK | BWFG |
|---|---|---|
| Relative Strength Index (RSI) | 53.80 | 47.69 |
| Support Level | $1.87 | $47.81 |
| Resistance Level | $2.23 | $49.71 |
| Average True Range (ATR) | 0.16 | 1.56 |
| MACD | 0.03 | -0.19 |
| Stochastic Oscillator | 86.47 | 37.09 |
Price Performance
Historical ComparisonAbout PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
About BWFG Bankwell Financial Group Inc.
Bankwell Financial Group Inc is a bank holding company, engaged in providing financial products and services. It offers products related to commercial lending, retail lending, depository services, and others. The bank's commercial lending products includes owner-occupied commercial real estate loans, commercial real estate investment loans, commercial loans to small and mid-sized businesses and real estate construction and development loans. The retail lending products include residential mortgage loans, home equity lines of credit, and consumer installment loans. Its depository products include checking, savings, money market, certificates of deposit, noninterest-bearing demand, and time deposits.